Monoclonal Antibody Halved Bronchiolitis Hospitalizations for Infants
A single dose of nirsevimab was effective in reducing visits to the ED for all-cause bronchiolitis by 55.4%, as well as reducing the risk of hospital admission for RSV bronchiolitis by 87.6%.